| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Genetics, Vol. 174, 2203-2213, December 2006, Copyright © 2006
doi:10.1534/genetics.106.061747
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Physiology, Pharmacology, Metabolism and Cardiovascular Sciences, University of Toledo College of Medicine, Toledo, Ohio 43614
1 Corresponding author: Department of Physiology, Pharmacology, Metabolism and Cardiovascular Sciences, University of Toledo College of Medicine, 3035 Arlington Ave., Block Health Science Bldg., Toledo, OH 43614.
E-mail: george.cicila{at}utoledo.edu
4.64 Mb. Two nonoverlapping substrains, S.R(ET3 x 1) and S.R(ET3 x 6), had significantly lower BP compared to the S strain, indicating the presence of two distinct BP QTL in the RNO3 q terminus. The RNO3 q terminus was fine mapped with newly developed polymorphic markers to characterize the extent of the congenic regions. The two RNO3 BP QTL regions were thus defined as within intervals of 0.051.12 and 0.721.25 Mb, respectively. Also important was our difficulty in fine mapping and marker placement in this portion of the rat genome (and thus candidate gene identification) using the available genomic data, including the rat genome sequence. This article has been cited by other articles:
![]() |
A. Y. Deng Genetic basis of polygenic hypertension Hum. Mol. Genet., October 15, 2007; 16(R2): R195 - R202. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |